POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI

Written By Yolandi Stanek

Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target.

Yolandi Stanek https://helloyo.com
Previous

FDA Acceptance of Auransa's IND Application for AU409 for Treatment of Patients with Hepatocellular Carcinoma
Next

Auransa and POLARISqb enter research collaboration finding treatments for neglected women's diseases